U.S. Auto Stock News

Inogen (INGN) just closed out FY 2025 with Q4 revenue of US$81.7 million, a basic EPS loss of US$0.26 and net income loss of US$7.1 million, set against trailing 12 month revenue of US$348.7 million and a basic EPS loss of US$0.86. Over recent quarters the company has seen quarterly revenue move from US$80.1 million in Q4 2024 to US$92.4 million in Q3 2025 before landing at US$81.7 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.15 and US$0.41 across that span. With...

Evommune (EVMN) has just wrapped up FY 2025 with Q4 revenue at US$0 million, a basic EPS loss of US$1.43 per share, and trailing twelve month revenue of US$13 million against a net loss of US$68.87 million. Over recent periods, the company has seen quarterly revenue move between US$0 million and US$10 million while quarterly EPS losses ranged from about US$1.43 to US$14.54 per share. This sets a clear picture of a business still investing heavily ahead of potential payoffs. For investors, the...

MARA Holdings: recent returns and business profile MARA Holdings (MARA) has caught investor attention after a mix of short term gains and longer term volatility, prompting a closer look at how its business model and recent returns fit together. The stock shows a 2.5% decline over the past day, alongside gains of 5.9% over the past week, about 42% over the past month and about 54% over the past 3 months. Year to date, the return stands at about 28%, with an estimated 11% decline over the past...

Lightwave Logic (LWLG) has been back in focus after progress on commercializing its electro optic polymer platform, including new foundry collaborations, a refreshed patent and licensing approach, and updates on production readiness for AI and data center customers. See our latest analysis for Lightwave Logic. Recent announcements on expanded silicon photonics foundry partnerships, progress on its Process Design Kit and a clearer licensing framework have coincided with a sharp acceleration in...

Artivion (AORT) just wrapped up FY 2025 with Q4 revenue of US$116.0 million and basic EPS of US$0.05, alongside net income of US$2.4 million. The company has seen revenue move from US$97.3 million and a basic EPS loss of US$0.39 in Q4 FY 2024 to US$116.0 million and US$0.05 in Q4 FY 2025. Trailing twelve month figures now sit at US$441.3 million of revenue and basic EPS of US$0.22 with net income of US$9.8 million, pointing to a business that is now covering its costs and starting to build...

Cross Country Healthcare (CCRN) just posted its FY 2025 numbers with Q4 revenue of US$236.8 million and a basic EPS loss of US$2.56, while trailing twelve month revenue came in at US$1.1 billion alongside a TTM basic EPS loss of US$2.93. Over recent quarters the company has seen revenue move from US$315.1 million in Q3 2024 to US$236.8 million in Q4 2025, with quarterly basic EPS shifting from a small profit of US$0.08 in Q3 2024 to a loss of US$2.56 in the most recent period. This points to...

Why CorVel’s AI rollout matters for stock watchers CorVel (CRVL) has launched CorVel Connected, a suite of artificial intelligence tools inside its CareMC claims platform, designed to organize complex claim data, support faster decisions, and reduce manual workload for claims professionals. See our latest analysis for CorVel. CorVel’s 19.3% 3 month share price return and 5.6% 1 month share price return suggest some near term momentum, although the 1 year total shareholder return of 48.3%...

Latest FY 2025 Earnings Snapshot Concentra Group Holdings Parent (CON) has just wrapped up FY 2025 with Q4 revenue of US$539.1 million and Basic EPS of US$0.27, setting the tone for how the market will read its profit story at a share price of US$23.60. The company has seen quarterly revenue move from US$465.0 million in Q4 FY 2024 to US$539.1 million in Q4 FY 2025. Over that same period, Basic EPS shifted from US$0.17 to US$0.27, setting up a picture where top line and per share earnings...

GATX (NYSE:GATX) has completed integration of the Wells Fargo railcar fleet ahead of schedule. The integration adds roughly 300 new customer accounts to GATX's rail portfolio. All fleet data from the Wells Fargo joint venture has been successfully migrated into GATX systems. The company reports sizable asset disposition gains in the same quarter as the integration milestone. For a railcar lessor like GATX, absorbing an entire fleet while keeping operations running smoothly is a major test...

Cheniere Energy Partners (CQP) has wrapped up FY 2025 with Q4 revenue of US$2.9b and basic EPS of US$2.38, while trailing twelve month revenue sits at US$10.8b and EPS at US$5.17. Over recent periods the company has seen quarterly revenue move between US$2.4b and US$3.0b and basic EPS range from US$0.80 to US$2.38. This gives investors a clear view of how top line and per share earnings have tracked into the latest release. With net income for the year and on a trailing basis remaining solid...

MKS Inc. has already reported its first-quarter 2026 results, with revenue rising to US$1,078 million from US$936 million a year earlier and net income increasing to US$84 million from US$52 million, lifting basic earnings per share from continuing operations to US$1.24. The quarter also capped months of higher analyst expectations and came after a February refinancing that pushed debt maturities into the 2030s and cut annual cash interest by about US$27 million, improving MKS's financial...

FIGS (FIGS) closed out FY 2025 with Q4 revenue of US$201.9 million and basic EPS of US$0.11, alongside trailing 12 month revenue of US$631.1 million and EPS of US$0.21 that has been described as posting a very large year on year gain. The company has seen quarterly revenue move from US$140.2 million in Q3 2024 to US$201.9 million in Q4 2025, while basic EPS shifted from a loss of US$0.01 in Q3 2024 to US$0.11 in the latest quarter. This has set up a story where forecast earnings growth of...

DXC Technology (DXC) just posted its Q3 2026 numbers with revenue of US$3.2 billion and basic EPS of US$0.62 on net income of US$107 million, setting a clear marker for how the turnaround is tracking. The company has seen quarterly revenue hold around the US$3.2 billion level over the past six periods, while basic EPS has moved from US$0.23 in Q2 2025 to US$0.62 in Q3 2026 as net income shifted from US$42 million to US$107 million over that span. For investors watching margins and earnings...

Definitive Healthcare (DH) has just closed out FY 2025 with Q4 revenue of US$61.5 million and a basic EPS loss of US$0.09, alongside trailing twelve month revenue of US$241.5 million and a TTM basic EPS loss of US$1.30. This gives investors a clear read on the current earnings profile. Over the past few quarters, revenue has ranged from US$59.2 million to US$62.7 million, while quarterly basic EPS losses have moved between US$0.07 and US$1.12. This sets the backdrop for a business that is...

Tandem Diabetes Care (TNDM) has wrapped up FY 2025 with Q4 revenue of US$290.4 million and a basic EPS loss of US$0.01, framing a year in which the trailing twelve months show US$1.0 billion of revenue and a basic EPS loss of US$3.04. Over recent quarters, revenue has moved from US$282.6 million in Q4 2024 to US$234.4 million in Q1 2025, then to US$240.7 million in Q2, US$249.3 million in Q3 and back to US$290.4 million in Q4 2025. Quarterly basic EPS has ranged from a small profit of US$0.01...

InfuSystem Holdings (INFU) closed out FY 2025 with fourth quarter revenue of US$36.2 million and basic EPS of US$0.10, as part of a trailing twelve month profile that shows revenue of US$143.4 million and EPS of about US$0.32. Over the past few reported periods, the company has seen quarterly revenue move from US$33.8 million and EPS of US$0.04 in Q4 2024 to US$36.2 million and EPS of US$0.10 in Q4 2025, with trailing twelve month EPS shifting from roughly US$0.11 to US$0.32 alongside higher...

Nomad Foods (NYSE:NOMD) has just posted its FY 2025 numbers, with fourth quarter revenue of €773.1 million and a basic EPS loss of €0.07, while trailing 12 month net income came in at €136.7 million on €3.0 billion of revenue and a 4.5% net margin that was below the prior year's 7.3%. Over recent quarters, revenue has moved from €793.4 million and EPS of €0.32 in Q4 2024 to a range between €746.9 million and €773.1 million in FY 2025. Quarterly EPS has swung between €0.21 and €0.44 before...

Akamai Technologies (AKAM) FY 2025 earnings snapshot Akamai Technologies (AKAM) has wrapped up FY 2025 with fourth quarter revenue of US$1,094.9 million and basic EPS of US$0.59, set against trailing twelve month revenue of US$4.2 billion and EPS of US$3.11 that frame the latest print within a fuller year view. Over recent periods the company has seen quarterly revenue move from US$1,019.9 million and EPS of US$0.93 in Q4 2024 through US$1,015.1 million and EPS of US$0.83 in Q1 2025 to...

Willdan Group (WLDN) closed out FY 2025 with Q4 revenue of US$173.7 million and basic EPS of US$1.28, supported by trailing twelve month revenue of US$681.6 million and EPS of US$3.63. Over the past few quarters, revenue has ranged from US$152.4 million in Q1 2025 to US$182.0 million in Q3 2025. Quarterly EPS has moved from US$0.33 to US$1.28, with trailing net profit margin at 7.7% compared with 4% a year earlier and reported earnings growth of 131.8% over that period. For investors, that...

Hormel Foods (NYSE:HRL) has partnered with OluKai to release a limited-edition SPAM inspired sandal collection, tying into the brand's strong identity in Hawai'i and abroad. The company has also signed a new licensing agreement with Disguise, Inc. to create costumes based on several Hormel brands. These moves extend Hormel's reach beyond grocery aisles into lifestyle and entertainment products. At a share price of $20.75, Hormel Foods sits against a backdrop of weak recent stock...

Puma Biotechnology (PBYI) closed FY 2025 with Q4 revenue of US$75.5 million and basic EPS of US$0.27, alongside net income of US$13.4 million that helped deliver trailing twelve month net income of US$31.1 million and basic EPS of US$0.62. Over recent quarters, the company has seen revenue move from US$46.0 million and EPS of US$0.06 in Q1 2025 to US$75.5 million and EPS of US$0.27 in Q4 2025. This positions investors to focus on how steadily improving margins underpin the current earnings...

Zymeworks (ZYME) closed out FY 2025 with Q4 revenue of US$2.5 million and a basic EPS loss of US$0.55, while net income excluding extra items was a loss of US$41.2 million, setting a cautious tone around margins and scale. Over the past four quarters, the company has seen total revenue range from US$2.5 million to US$48.7 million per quarter and basic EPS swing between a small profit of US$0.03 and a loss of US$0.55. This gives investors a wide earnings range to weigh against forecasts and...

Cytek Biosciences (CTKB) closed out FY 2025 with Q4 revenue of US$62.1 million and a basic EPS loss of US$0.34, alongside a trailing twelve month revenue base of US$201.5 million and a basic EPS loss of US$0.52. Over recent periods, the company has seen quarterly revenue move from US$57.5 million in Q4 2024 to US$62.1 million in Q4 2025, while basic EPS shifted from a profit of US$0.07 in Q4 2024 to a loss of US$0.34 in Q4 2025. This sets up a story that puts margin pressure and the path back...

In April 2026, HCA Healthcare held its annual shareholder meeting, reported voting results that rejected two shareholder proposals, announced a leadership change in marketing and corporate affairs, and filed an omnibus shelf registration for common stock, preferred stock, and debt securities. These governance, leadership, and financing developments come alongside HCA’s continued emphasis on nursing excellence and community partnerships, highlighting how corporate decisions intersect with...